BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32276872)

  • 1. Incidence of Clostridioides difficile infection at a Saudi Tertiary Academic Medical Center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10-year period.
    Aljafel NA; Al-Shaikhy HH; Alnahdi MA; Thabit AK
    J Infect Public Health; 2020 Aug; 13(8):1156-1160. PubMed ID: 32276872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three current Clostridioides difficile infection guidelines: IDSA/SHEA, ESCMID, and ACG guidelines.
    Thabit AK; Alsolami MH; Baghlaf NA; Alsharekh RM; Almazmumi HA; Alselami AS; Alsubhi FA
    Infection; 2019 Dec; 47(6):899-909. PubMed ID: 31428991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.
    Alzouby S; Baig K; Alrabiah F; Shibl A; Al-Nakhli D; Senok AC
    J Infect Public Health; 2020 Jul; 13(7):1012-1017. PubMed ID: 31831398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An insight into
    Thabit AK; Aljedaani HJ; Alghamdi RH; Badahdah RM; Lashkar MO; Alnajjar A
    Expert Rev Gastroenterol Hepatol; 2023; 17(8):805-810. PubMed ID: 37480286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk prediction for 30-day mortality among patients with
    Chiang HY; Huang HC; Chung CW; Yeh YC; Chen YC; Tien N; Lin HS; Ho MW; Kuo CC
    Antimicrob Resist Infect Control; 2019; 8():175. PubMed ID: 31749963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with Clostridium difficile treatment guidelines: effect on patient outcomes.
    Crowell KT; Julian KG; Katzman M; Berg AS; Tinsley A; Williams ED; Koltun WA; Messaris E
    Epidemiol Infect; 2017 Aug; 145(11):2185-2192. PubMed ID: 28578710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    Bishop EJ; Tiruvoipati R
    J Antimicrob Chemother; 2022 Dec; 78(1):21-30. PubMed ID: 36441203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of
    Kaabia NM; Al Basha H; Bukhari DA; Bouafia N; Al Qahtani AN; Alshahrani AM; Aboushanab IM; Al Odayani AN
    Saudi Med J; 2024 Feb; 45(2):188-193. PubMed ID: 38309732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
    Robin C; Héquette-Ruz R; Guery B; Boyle E; Herbaux C; Galperine T
    Med Mal Infect; 2017 Dec; 47(8):532-539. PubMed ID: 28823390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of
    Deac IŞ; Ofrim AM; Fărcaş RA; Grad S; Popa ŞL; Dumitraşcu DL
    Med Pharm Rep; 2024 Jan; 97(1):5-11. PubMed ID: 38344334
    [No Abstract]   [Full Text] [Related]  

  • 12. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.
    Al-Tawfiq JA; Rabaan AA; Bazzi AM; Raza S; Noureen M
    Am J Infect Control; 2020 Oct; 48(10):1152-1157. PubMed ID: 32122671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria.
    Starzengruber P; Segagni Lusignani L; Wrba T; Mitteregger D; Indra A; Graninger W; Presterl E; Diab-Elschahawi M
    Wien Klin Wochenschr; 2014 Jul; 126(13-14):427-30. PubMed ID: 24903143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
    Mulherin DW; Hutchison AM; Thomas GJ; Hansen RA; Childress DT
    Infection; 2014 Dec; 42(6):999-1005. PubMed ID: 25129565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.
    Patel I; Wungjiranirun M; Theethira T; Villafuerte-Galvez J; Castillo N; Akbari M; Alonso CD; Leffler DA; Kelly CP
    J Antimicrob Chemother; 2017 Feb; 72(2):574-581. PubMed ID: 28115504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
    Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
    Clin Infect Dis; 2021 Sep; 73(5):755-757. PubMed ID: 34492699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
    Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
    Clin Infect Dis; 2021 Sep; 73(5):e1029-e1044. PubMed ID: 34164674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Connecticut medical providers' concordance with 2017 IDSA/SHEA
    Luc CM; Olson D; Banach DB; Clogher P; Hadler J
    Infect Control Hosp Epidemiol; 2021 May; 42(5):549-556. PubMed ID: 33234174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).
    Viprey VF; Granata G; Vendrik KEW; Davis GL; Petrosillo N; Kuijper EJ; Vilken T; Lammens C; Schotsman JJ; Benson AD; Cataldo MA; van der Kooi TII; Wilcox MH; Davies KA;
    J Hosp Infect; 2023 Jan; 131():213-220. PubMed ID: 36462673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of Clostridioides (Clostridium) difficile infection in adults: a summary of recommendations from the 2017 IDSA/SHEA clinical practice guideline.
    Ma J; Dubberke E
    Pol Arch Intern Med; 2019 Mar; 129(3):189-198. PubMed ID: 30457126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.